A bidding war between Novo Nordisk and Pfizer has broken into the open for Metsera, which focuses on developing drugs to ...

“Into 2026, we expect only modest sequential improvement,” wrote Evercore ISI’s Elizabeth Anderson, adding: “Management ...

It’s no secret that our bodies’ ability to ward off pathogens and mount strong vaccine responses weakens with age, but ...

Join national leaders on Dec 4 to discover how Houston is accelerating life sciences growth and shaping the future of biotech ...

A bidding war has broken into the open for the obesity-focused Metsera, with Novo Nordisk aiming to outbid Pfizer for the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

In September, the Food and Drug Administration released its recent complete response letter (CRL) to Lykos Therapeutics, ...

Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...

The Trump administration has dismantled big chunks of the federal agency focused on mental health and addiction treatment, ...

ACIP must endorse vaccination for all health care workers under 65. That would ensure that insurers cover the shots without ...

WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price ...

Bausch Health recently stopped participating in Medicaid and a federal government drug discount program known as 340B ...